Literature DB >> 10320720

Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats.

J D Carlson1, R D Pearlstein, J Buchholz, R P Iacono, G Maeda.   

Abstract

The pedunculopontine nucleus (PPN) located in the mesopontine tegmentum is innervated by descending projections from nuclei in the basal ganglia. The present study was performed to determine whether nigrostriatal dopaminergic neuron degeneration is associated with changes in PPN metabolic activity. Unilateral nigrostriatal lesioning was performed by injecting 6-hydroxydopamine (6-OHDA) into the substantia nigra pars compacta in 10 rats. Six of these animals exhibited apomorphine-induced rotations contralateral to the lesion and were included in the experimental group for determination of regional cerebral metabolic rate for glucose (rCMRglucose) along with five sham-lesioned and five normal controls. All studies were performed 13-15 days after lesioning using [14]C-2-deoxyglucose autoradiography. Significant hemispheric differences in metabolic activity were observed only in the 6-OHDA lesioned animals. Increased rCMRglucose was found in the globus pallidus (+63%) ipsilateral to the lesion as compared to the contralateral hemisphere, and reduced rCMRglucose in the primary motor, sensory, and auditory cortex (-7%, -12% and -7%, respectively), and in the subthalamic nucleus (-6%). Metabolic activity within the PPN ipsilateral to the lesion was significantly greater than the contralateral hemisphere (P<0.05; lesion 57+/-8, nonlesion 52+/-5), and significantly greater than the sham-lesioned side of the sham rat (P<0.05; sham lesion 47+/-5). No hemispheric differences were observed in the lateral dorsal tegmental nucleus. These observations offer further support for a role of the PPN in Parkinson's and for the utility of the rodent unilateral 6-OHDA model in defining the pathophysiologic significance of the mesopontine tegmental striatal-motor interfaces in basal ganglia disease. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320720     DOI: 10.1016/s0006-8993(99)01268-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Authors:  Yilong Ma; Shichun Peng; Phoebe G Spetsieris; Vesna Sossi; David Eidelberg; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-30       Impact factor: 6.200

2.  Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat.

Authors:  Takako Kita; Hitoshi Kita
Journal:  Eur J Neurosci       Date:  2010-12-31       Impact factor: 3.386

Review 3.  Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board.

Authors:  Roger L Albin; D James Surmeier; Cecilia Tubert; Martin Sarter; Martijn L T M Müller; Nicolaas I Bohnen; William T Dauer
Journal:  Mov Disord       Date:  2018-11-06       Impact factor: 10.338

4.  Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.

Authors:  Yunmin Ding; Jacqueline Restrepo; Lisa Won; Dong-Youn Hwang; Kwang-Soo Kim; Un Jung Kang
Journal:  Neurobiol Dis       Date:  2007-04-10       Impact factor: 5.996

5.  Functional disconnection of the substantia nigra pars compacta from the pedunculopontine nucleus impairs learning of a conditioned avoidance task.

Authors:  Mariza Bortolanza; Evellyn C Wietzikoski; Suelen L Boschen; Patricia A Dombrowski; Mary Latimer; Duncan A A Maclaren; Philip Winn; Claudio Da Cunha
Journal:  Neurobiol Learn Mem       Date:  2010-06-01       Impact factor: 2.877

6.  Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.

Authors:  M Gomez-Gallego; E Fernandez-Villalba; A Fernandez-Barreiro; M T Herrero
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

Review 7.  The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability.

Authors:  Eugenio Scarnati; Tiziana Florio; Annamaria Capozzo; Giuseppina Confalone; Paolo Mazzone
Journal:  J Neural Transm (Vienna)       Date:  2010-12-16       Impact factor: 3.575

8.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

9.  Abnormal regional brain function in Parkinson's disease: truth or fiction?

Authors:  Yilong Ma; Chengke Tang; James R Moeller; David Eidelberg
Journal:  Neuroimage       Date:  2008-10-18       Impact factor: 6.556

10.  Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.

Authors:  Cindy Casteels; Erwin Lauwers; Guy Bormans; Veerle Baekelandt; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.